Menu
  • Join
  • Login
  • Contact
 

Search abstracts


DRUG USE EVALUATION FOR FLUNITRAZEPAM IN A 2000-BED MEDICAL CENTER IN TAIWAN

  • At: 2015 FIP Congress in Düsseldorf (Germany)
  • Type: Poster
  • By: WU, Shang-Hua (China Medical University, School pf pharmacy, Taiwan (R.O.C.), China Taiwan)
  • Co-author(s): Shang-Hua Wu
  • Abstract:

    Flunitrazepam (i.e., FM2), 3-class controlled substance in Taiwan, has the longer half-life. FM2 is approved for insomnia and used for anxiety and muscle relaxation, as off-label use. 

    A secondary data analysis using 2000-bed China Medical University Hospital (CMUH) in-house Medication Unitization Evaluation (MUE) databases was conducted. The FM2

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses